Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
EJNMMI Physics
|
July 23, 2016
An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studies
N E Makris, R Boellaard, C W Menke, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2021
[<sup>18</sup>F]FES uptake in the pituitary gland and white matter of the brain
R Iqbal, C W Menke-van der Houven van Oordt, D E Oprea-Lager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2018
FDG PET and FES PET Predict PFS on Endocrine Therapy-Letter
Lemonitsa H Mammatas, Erik J van Helden, Henk M W Verheul, et al.
Medical Physics
|
October 6, 2014
Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses
N E Makris, F H P van Velden, M C Huisman, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 15, 2008
[Cardiotoxicity of trastuzumab of significance in the adjuvant treatment of breast cancer]
C W Menke-van der Houven van Oordt, H J M Fliervoet, C M P W Mandigers, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 12, 2020
[Prioritising breast cancer care during the corona crisis]
Y A Civil, T P van Iersel, C W Menke-van der Houven van Oordt, et al.
Frontiers in Medicine
|
May 31, 2024
The development process of 'fit-for-purpose' imaging biomarkers to characterize the tumor microenvironment
Jakoba J Eertink, Idris Bahce, John C Waterton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 24, 2015
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab
Nikolaos E Makris, Ronald Boellaard, Arthur van Lingen, et al.
Cancer Metastasis Reviews
|
July 12, 2017
Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
E J van Helden, C W Menke-van der Houven van Oordt, M W Heymans, et al.
Cancer Chemotherapy and Pharmacology
|
April 11, 2020
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study
L H Mammatas, A S Zandvliet, M Rovithi, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
EJNMMI Physics
|
July 23, 2016
An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studies
N E Makris, R Boellaard, C W Menke, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2021
[<sup>18</sup>F]FES uptake in the pituitary gland and white matter of the brain
R Iqbal, C W Menke-van der Houven van Oordt, D E Oprea-Lager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2018
FDG PET and FES PET Predict PFS on Endocrine Therapy-Letter
Lemonitsa H Mammatas, Erik J van Helden, Henk M W Verheul, et al.
Medical Physics
|
October 6, 2014
Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses
N E Makris, F H P van Velden, M C Huisman, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 15, 2008
[Cardiotoxicity of trastuzumab of significance in the adjuvant treatment of breast cancer]
C W Menke-van der Houven van Oordt, H J M Fliervoet, C M P W Mandigers, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 12, 2020
[Prioritising breast cancer care during the corona crisis]
Y A Civil, T P van Iersel, C W Menke-van der Houven van Oordt, et al.
Frontiers in Medicine
|
May 31, 2024
The development process of 'fit-for-purpose' imaging biomarkers to characterize the tumor microenvironment
Jakoba J Eertink, Idris Bahce, John C Waterton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 24, 2015
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab
Nikolaos E Makris, Ronald Boellaard, Arthur van Lingen, et al.
Cancer Metastasis Reviews
|
July 12, 2017
Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
E J van Helden, C W Menke-van der Houven van Oordt, M W Heymans, et al.
Cancer Chemotherapy and Pharmacology
|
April 11, 2020
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study
L H Mammatas, A S Zandvliet, M Rovithi, et al.
Page
of 8